| Continuing Medical Education
The ESMO label for this program is being sought. Attendees will receive a certificate of attendance at the end of the meeting.
Who Should Attend
This educational program is intended for oncologists, radiation therapists, thoracic surgeons and other physicians in active
clinical practice interested and/or involved in the management of patients with thoracic cancer.No specialized knowledge or
skills other than a general familiarity with cancer and its treatment is required for successful participation in this program.
©
2006 Imedex®, Inc |
Objectives
After successfully completing this medical education program participants should be able to:
-
Discuss and evaluate the available methods for screening and staging of lung cancer
-
Recommend the most appropriate management approaches for non-small cell lung cancer (NSCLC)
-
Recommend the most appropriate management strategies for small cell lung cancer
-
Comment on controversies in management of locally advanced NSCLC
-
Discuss treatment options for NSCLC therapy-associated side-effects
-
Outline management strategies for esophageal cancer
-
Outline management strategies for mesothelioma
-
Comment on challenges in lung cancer clinical trials
-
Comment on promising new agents for the treatment of lung cancer
-
Discuss the latest options for management of treatmentassociated brain and bone metastases
|
